Earnings

Sundial's EBITDA plummeted to a $0.7 million loss during Q1 2022 after $18.4 million during the previous quarter

Q1 revenue was comprised of approximately 61 per cent in cannabis 2.0 product sales

Supply chain issues, project delays and seasonal weakness contributed to decreased revenue during the first quarter

The company also reported a 14 per cent decrease in revenue

The firm had an adjusted EBITDA of US$105.5 million, up 4.5 per cent from US$100.9 million during the fourth quarter of 2021

Its Valley, Anandia and Whisler Alpha Lake are expected to be closed by the fourth quarter

Nova’s sales growth resulted from new retail stores, transition to Value Buds low-cost model

Last March, the company reported a record 2021 revenue of US1.2 billion.

Adjusted EBITDA went to a negative $9.3 million from a positive $7.7 million in the last year

The company currently has 13 subsidiaries in 10 different countries

The company reported around $26.6M in losses this year

Sundials's EBITDA increased to $18.4 million during the fourth quarter, up 75 per cent from the previous quarter

Edible product sales represent 87% of net revenue in Q4 2021

Decibel marked its sixth consecutive quarter of positive EBITDA, reporting $1.5 million during the fourth quarter

Numinus' gross margin improved to 29.1 per cent during Q2 2022 following acquisitions of Mindspace Psychology Services Inc. and the Neurology Centre of Toronto

Following acquisitions and business transition, cannabis producer expects continued growth during 2022

The company says it has a 20% market share in Germany with its whole flower, extracts and Dronabinol products

The Canadian company sold a record of $5.18 million in cannabis products last December

The firm says it's reformulated its concentrate lines to meet client expectations related to terpenes

The firm is forecasting 2022 revenue of at least US$1.3B

And 2022 is looking like a bright year for international medical cannabis markets

But the company's CEO says it's already facing economic headwinds this year

But the firm acknowledges a market slowdown in Q4 it was 'not immune to'

Its majority shareholder Alcanna is set to be bought by Sundial for $346M at the end of March

The firm says the charges give it a 'clean slate' for future growth

The company continues to expand domestically and internationally

The company says it expects revenue from capital expenditure projects to ramp up this year

The firm says its performance in New Jersey has been strong, and is prepared for adult-use sales to launch there

The firm maintained positive adjusted EBITDA in every quarter last year

The Mary Jones brand is set to launch in California by the end of the month

The company says it's well positioned for domestic and international growth

After a reverse takeover and other business combinations, the firm's CEO says HYTN is on track for future growth

It's the firm's 8th consecutive quarter of positive cash flow from operations

The firm's annual losses reached US$396.1 million

But overall net income tripled to US$2.1M

With a business transition mostly complete, the firm says it expects strong growth in 2022

Company stock hit a 4-year low on Friday

The stalwart pot firm is projecting a return to EBITDA-positivity later this year, as it pivots to adult-use sales

Taking a recent majority stake in a baby food maker, Neptune joins other pot firms expanding broadly into different CPG categories

But sales for the firm's BioSteel sports drinks and Storz & Bickel vaporizers have been rising